Total 628 words used.
InfinityRx is an affordability program administrator for copay assistance programs. Using proprietary technology, shared resources, and insights, InfinityRx builds strategic partnerships with pharma and biotech companies to deliver progressive, efficient, and cost-effective Patient Support Programs (PSP). As champions for health equity, InfinityRx helps patients achieve their therapeutic goals through access and affordability, while simultaneously cultivating growth and profitability for their clients.
In 2018, InfinityRx founders, leadership with decades of pharmaceutical experience in the inner workings of drug service providers and trade distribution, recognized a biased market for patients in need of pharmaceutical therapy and aspired to build an organization that would address the needs of the patient in their journey through care. Focusing on copay assistance for pharmaceutical drugs and beginning with technology, the founder’s recognized that most claim’s processing software was legacy technology that was repurposed, so they started building what is now InfinityRx Claims Processor® (ICP) – patent approved in 2022.
New technology advanced the development of new solutions and improved customer services, inspiring the introduction of Infinity Brand Loyalty® (IBL). The combined power of their assets, IBL and ICP, ensure no step from launch to patient access has been overlooked. Through IBL they deliver advisory services while optimizing gross-to-net (GTN) for maximum program efficiency and valuable ROI. They developed policies that overcome patient access barriers and through diverse patient engagement tools they foster patient adherence to sustain brand loyalty. They execute PSP strategies through ICP, connecting with all sites of care. They adjudicate pharmacy and medical claims, deliver comprehensive data from all stakeholders, and provide the ability to make on demand program changes in real-time. Program administration is achieved through sophisticated technology that leverages insights learned from captured data to deliver cost efficient PSP and patient-provider support. InfinityRx services reshape the patient experience and empower their clients with data rich strategies.
2022 was the breakthrough year for InfinityRx. Empowered by technology and advanced solutions for affordability, access, and adherence, they simplified the process for all parties involved in the dispensing of medication, including physicians, manufacturers, pharmacies, and patients. These solutions enabled InfinityRx to deliver progressive, efficient, and cost-effective PSP and advanced technology solutions to healthcare organizations enabling prescribers and drug service providers to furnish value-added services to their patients. The InfinityRx experience for its clients and patients is more advanced and user intuitive compared to the competition. What takes minutes to do on ICP can take weeks to months on other systems. InfinityRx clients have access and control of their affordability programs, and their patients benefit from their ability to reply to their needs in a timely manner.
With the expertise of the founders and InfinityRx leadership, and their outstanding abilities to identify talent and inspire, they built an elite team of technology experts and industry leaders to provide the services required to compete in a highly competitive marketplace. They have taken InfinityRx, industry stakeholders, and especially the patients they serve to new levels of satisfaction. [REDACTED FOR PUBLICATION].
A number of pharmaceutical manufacturer clients have been the topic of many discussions in the brief time since the formation of InfinityRx. Greg Savino, founder, and CEO says, “As we continue to progress in our technology and perfect our services, InfinityRx will be the vendor of choice across the spectrum. Ensuring that we create the right solutions, it is important to discuss the problems, something that many in the industry brush under the rug. We are not here to comply; we are here to defy and do so in a way that promotes patient access to medications and therapy, driven by technology and ease across the continuum of care.”
Nomination Title: InfinityRx Technical Support Strategy and Implementation
